Related Experiment Video
Updated: Nov 13, 2025

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Chemically modified and conjugated antimicrobial peptides against superbugs.
Wenyi Li1, Frances Separovic2, Neil M O'Brien-Simpson1
1Melbourne Dental School, Centre for Oral Health Research, University of Melbourne, VIC 3010, Australia. wenyi.li@unimelb.edu.au neil.obs@unimelb.edu.au and Bio21 Institute, University of Melbourne, VIC 3010, Australia.
Antimicrobial peptides (AMPs) offer a promising solution to combat rising antimicrobial resistance (AMR). Chemical modifications enhance AMPs
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Microbiology
Background:
- Antimicrobial resistance (AMR) poses a significant global health threat, projected to surpass cancer deaths by 2050.
- Novel antimicrobial agents that circumvent AMR are urgently needed.
- Antimicrobial peptides (AMPs) show potent activity against diverse bacteria with low AMR induction potential.
Purpose of the Study:
- To review recent synthetic strategies for developing next-generation antimicrobial agents.
- To explore chemical modifications that enhance AMP efficacy and therapeutic index.
- To guide future research directions in AMP development for biomedical applications.
Main Methods:
- Review of recent synthetic efforts in antimicrobial peptide (AMP) development.
- Analysis of chemical modifications such as lipidation, glycosylation, and multimerization.
- Exploration of bio-orthogonal chemistry applications in AMP design.
Main Results:
- Various chemical modifications can significantly enhance AMP antimicrobial activity and therapeutic properties.
- Rational design and synthesis are key to developing effective AMP analogues.
- Novel bio-orthogonal chemistry offers new avenues for AMP development.
Conclusions:
- Chemically modified AMPs represent a promising strategy for next-generation antimicrobials.
- Continued research into AMP modification and application is crucial for addressing AMR.
- Peptidomimetics derived from AMPs hold potential for diverse biomedical challenges.
More Related Videos
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Development of Antibiotic Resistance
Biological Methods for Microbial Control
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antibiotic Selection
Microorganisms in Medicine and Therapeutics

